Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-24-021197

CEO and President gave up 2,190 shares (to pay taxes)

  • CEO and President acquired 8,990 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KLEMP WALTER V CEO and President 2024-06-22 Option exercise +8,990 58,483 D
KLEMP WALTER V CEO and President 2024-06-22 Shares withheld for taxes −2,190 $3.74 $8,191 56,293 D
Derivatives
KLEMP WALTER V CEO and President 2024-06-22 Option exercise · Restricted Stock Units −8,990 114,134 D
Loading xslF345X05/rdgdoc.xml…